BSYI — BioSyntech Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for BioSyntech, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2005 March 31st | 2006 March 31st | 2007 March 31st | R2008 March 31st | 2009 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.901 | 10.9 | 11.9 | 2.84 | 3.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.225 | 0.301 | 0.847 | 0.889 | 1.34 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 1.21 | 11.4 | 13 | 3.92 | 5.36 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.72 | 2.58 | 2.46 | 2.19 | 1.84 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 4.76 | 14.7 | 16.4 | 6.12 | 7.2 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.06 | 4.25 | 1.94 | 1.92 | 11.9 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 6.52 | 6.14 | 5.24 | 4.46 | 13.9 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -1.76 | 8.59 | 11.2 | 1.66 | -6.66 |
Total Liabilities & Shareholders' Equity | 4.76 | 14.7 | 16.4 | 6.12 | 7.2 |
Total Common Shares Outstanding |